Adwan L, Subaiea GM, Zawia NH (2014) Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer’s disease related biomarkers. Neuropharmacology 79:596–602
Article CAS PubMed PubMed Central Google Scholar
Ahmadi Rastegar D, Hughes LP, Perera G, Keshiya S, Zhong S, Gao J, Halliday GM, Schüle B, Dzamko N (2022) Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages. Npj Parkinson’s Dis 8:34
Aid S, Langenbach R, Bosetti F (2008) Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. J Neuroinflammation 5:1–14
Akitake Y, Nakatani Y, Kamei D, Hosokawa M, Akatsu H, Uematsu S, Akira S, Kudo I, Hara S, Takahashi M (2013) Microsomal prostaglandin E synthase-1 is induced in alzheimer’s disease and its deletion mitigates alzheimer’s disease-like pathology in a mouse model. J Neurosci Res 91:909–919
Article CAS PubMed Google Scholar
Alhouayek M, Muccioli GG (2014) COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. Trends Pharmacol Sci 35:284–292
Article CAS PubMed Google Scholar
Al-Kuraishy HM (2016) Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy. J Intercult Ethnopharmacol 5:7
Al-Kuraishy HM, Al-Gareeb AI (2019) Effects of rosuvastatin on metabolic profile: versatility of dose-dependent effect. J Adv Pharm Technol Res 10:33
Article CAS PubMed PubMed Central Google Scholar
Al-kuraishy HM, Al-windy SA (2013) Experimental antibacterial activity of selective cyclooxygenase antagonist. Int J Pharm Chem Biol Sci 3(3):692–699
Alkuraishy HM, Al-Gareeb AI, Waheed HJ (2018) Lipoprotein-associated phospholipase A2 is linked with poor cardio-metabolic profile in patients with ischemic stroke: a study of effects of statins. J Neurosci Rural Pract 9:496–503
Article PubMed PubMed Central Google Scholar
Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI (2020a) Involvement of orexinergic system in psychiatric and neurodegenerative disorders: a scoping review. Brain Circ 6:70
Article PubMed PubMed Central Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Naji MT, Al-Mamorry F (2020b) Role of vinpocetine in ischemic stroke and poststroke outcomes: a critical review. Brain Circ 6:1
Article PubMed PubMed Central Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, Batiha GE-S (2021) Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: the enigmatic entity. Eur J Pharmacol 904:174196
Article CAS PubMed PubMed Central Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Mukerjee N, Al-Hamash SMJ, Al-Maiahy TJ, Batiha GE-S (2022a) 5-HT/CGRP pathway and Sumatriptan role in Covid-19. Biotechnol Genet Eng Rev. https://doi.org/10.1080/02648725.2022.2108996
Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE-S (2022b) Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19. Biotechnol Genet Eng Rev. https://doi.org/10.1080/02648725.2022.2122290
Al-Kuraishy HM, Al-Gareeb AI, Alsayegh AA, Hakami ZH, Khamjan NA, Saad HM, Batiha GE-S, De Waard M (2022c) A potential link between visceral obesity and risk of Alzheimer’s disease. Neurochem Res 48:745
Al-kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE-S (2022d) Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects. Inflammopharmacology 31:1–10
PubMed PubMed Central Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE-S (2023a) Cannabinoids Receptors in COVID-19: Perpetrators and Victims. Curr Med Chem. https://doi.org/10.2174/0929867329666220829145029
Al-kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Ahmed EA, Batiha GES (2023b) SARS-COV-2 infection and Parkinson’s disease: possible links and perspectives. J Neurosci Res. https://doi.org/10.1002/jnr.25171
Alomair BM, Al-kuraishy HM, Al-Gareeb AI, Al-Hamash SM, De Waard M, Sabatier J-M, Saad HM, El-Saber Batiha G (2022) Montelukast and acute coronary syndrome: the endowed drug. Pharmaceuticals 15:1147
Article CAS PubMed PubMed Central Google Scholar
Alorabi M, Cavalu S, Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Negm WA, Youssef A, El-Kadem AH, Saad HM, Batiha GE-S (2022) Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress. Biomed Pharmacother 152:113225
Article CAS PubMed Google Scholar
Alsubaie N, Al-kuraishy HM, Al-Gareeb AI, Alharbi B, De Waard M, Sabatier J-M, Saad HM, Batiha GE-S (2022) Statins use in Alzheimer disease: bane or boon from frantic search and narrative review. Brain Sci 12:1290
Article CAS PubMed PubMed Central Google Scholar
Al-Thomali AW, Al-kuraishy HM, Al-Gareeb AI, Al-buhadiliy AK, De Waard M, Sabatier J-M, Khan Khalil AA, Saad HM, Batiha GE-S (2022) Role of neuropilin 1 in COVID-19 patients with acute ischemic stroke. Biomedicines 10:2032
Article CAS PubMed PubMed Central Google Scholar
Balderas E, Sánchez-Cárdenas C, Chávez J, De La Vega BJ, Gomez-Lagunas F, Trevino C, Darszon A (2013) The anti-inflammatory drug celecoxib inhibits t-type Ca2+ currents in spermatogenic cells yet it elicits the acrosome reaction in mature sperm. FEBS Lett 587:2412–2419
Article CAS PubMed Google Scholar
Batiha GE-S, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E (2022) SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close. Inflammopharmacology 29:1–20
Baune BT (2015) Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention? Curr Opin Psychiatry 28:148–154
Becker C, Jick S, Meier C (2011) NSAID use and risk of Parkinson disease: a population-based case-control study. Eur J Neurol 18:1336–1342
Article CAS PubMed Google Scholar
Behl T, Kaur G, Bungau S, Jhanji R, Kumar A, Mehta V, Zengin G, Brata R, Hassan SSu, Fratila O (2020) Distinctive evidence involved in the role of endocannabinoid signalling in Parkinson’s disease: a perspective on associated therapeutic interventions. Int J Mol Sci 21:6235
Article CAS PubMed PubMed Central Google Scholar
Bindu S, Mazumder S, Bandyopadhyay U (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol 180:114147
Article CAS PubMed PubMed Central Google Scholar
Boyd-Mutinga FA, Topaz GR, Silva CL, Berger NJ, Egbujie K, De Rodriguez SF, Iyungu C, Sosa HM, Begay SC, Stieglitz KA (2020) Characterization of predicted binding modes of acetylsalicylic acid (aspirin) to the COX-2 Target. FASEB J 34:1–1
Brakedal B, Tzoulis C, Tysnes O-B, Haugarvoll K (2021) NSAID use is not associated with Parkinson’s disease incidence: a Norwegian prescription database study. PLoS ONE 16:e0256602
Article CAS PubMed PubMed Central Google Scholar
Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP (1999) Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br J Pharmacol 126:563–567
Article CAS PubMed PubMed Central Google Scholar
Buer JK (2014) Origins and impact of the term ‘NSAID.’ Inflammopharmacology 22:263–267
Article CAS PubMed Google Scholar
Calabrese V, Bates TE, Stella AMG (2000) NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem Res 25:1315–1341
Article CAS PubMed Google Scholar
Calvo-Rodríguez M, Núñez L, Villalobos C (2015) Non-steroidal anti-inflammatory drugs (NSAIDs) and neuroprotection in the elderly: a view from the mitochondria. Neural Regen Res 10:1371
Article PubMed PubMed Central Google Scholar
Carapellotti AM, Stevenson R, Doumas M (2020) The efficacy of dance for improving motor impairments, non-motor symptoms, and quality of life in Parkinson’s disease: a systematic review and meta-analysis. PLoS ONE 15:e0236820
Article CAS PubMed PubMed Central Google Scholar
Carrasco E, Casper D, Werner P (2005) Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity. J Neurosci Res 81:121–131
Article CAS PubMed Google Scholar
Carrasco E, Casper D, Werner P (2007) PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE2 neurotoxicity. J Neurosci Res 85:3109–3117
留言 (0)